Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | AZN | AMGN | GILD | BMY |
| Company | Horizon Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 116.34 | 202.81 | 354.25 | 138.06 | 60.00 |
| High | 116.38 | 203.37 | 356.90 | 138.54 | 60.12 |
| Low | 116.26 | 201.56 | 350.94 | 136.06 | 59.29 |
| Latest | 116.30 | 201.74 | 352.46 | 136.70 | 59.40 |
| Change | +0.05 | -3.06 | -2.84 | -0.94 | -0.77 |
| % Change | +0.04% | -1.49% | -0.80% | -0.68% | -1.28% |
| Volume | 28,881,200 | 677,174 | 1,088,982 | 1,752,737 | 3,538,910 |
| 20-Day Average Volume | 3,994,490 | 1,841,577 | 2,410,409 | 5,203,190 | 9,690,739 |
| Previous Close | 116.25 | 204.80 | 355.30 | 137.64 | 60.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 197.80 | 350.07 | 138.70 | 59.00 |
| 20-Day Raw Stochastic | 95.09% | 78.26% | 72.22% | 27.75% | 52.03% |
| 20-Day Relative Strength | 80.29 | 54.78 | 48.67 | 43.22 | 51.66 |
| Weighted Alpha | +49.30 | +44.44 | +25.13 | +29.29 | +28.30 |
| Today's Opinion | 88% Buy | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 40% Buy | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | -0.18% since 04/13/26 | +0.81% since 04/13/26 | -1.88% since 04/13/26 | +2.40% since 04/13/26 |
| Low | 115.66 on 09/29/23 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 136.06 on 04/20/26 | 57.22 on 04/15/26 |
| High | 116.38 on 10/05/23 | 205.30 on 04/17/26 | 356.69 on 04/17/26 | 141.40 on 04/14/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +9.96% since 03/20/26 | +1.40% since 03/20/26 | -0.58% since 03/20/26 | +3.44% since 03/20/26 |
| Low | 114.75 on 09/11/23 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 116.38 on 10/05/23 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +12.23% since 01/20/26 | +6.55% since 01/20/26 | +9.88% since 01/20/26 | +9.66% since 01/20/26 |
| Low | 98.80 on 08/03/23 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 53.54 on 01/21/26 |
| High | 116.38 on 10/05/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +20.36% since 10/20/25 | +16.27% since 10/20/25 | +10.80% since 10/20/25 | +36.40% since 10/20/25 |
| Low | 90.56 on 05/16/23 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 116.38 on 10/05/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 317,625,952 | 191,750,080 | 170,841,792 | 122,851,192 |
| Shares Outstanding, K | 228,995 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 3,629,040,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 521,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 944,960,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 127,070,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.03 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/01/23 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 21.89 | 15.99 | 17.00 | 9.59 |